Skip to main content

Table 1 Demographic and clinical findings of the enrolled pediatric population

From: Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy

 

*RIs children

N. evaluated children

91

Age (years) (mean/SD*)

7.4 ± 2.3

1–3 years old

20

3–6 years old

42

6–12 years old

29

Gender Male/Female

47/44

N. of children with family history of atopy/ without family history of atopy

49/42

N. of children with allergy/without allergy

35/56

N. of children exposed smoke/ unexposed smoke

45/46

  1. *RIs recurrent infections, SD standard deviation